Enhancing in vitro Cartilge Synthesis for Human Therapy

Information

  • Research Project
  • 6647004
  • ApplicationId
    6647004
  • Core Project Number
    R44AR046133
  • Full Project Number
    7R44AR046133-04
  • Serial Number
    46133
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/1/2003 - 21 years ago
  • Project End Date
    4/30/2005 - 19 years ago
  • Program Officer Name
    QUATRANO, LOUIS A
  • Budget Start Date
    5/1/2003 - 21 years ago
  • Budget End Date
    4/30/2004 - 20 years ago
  • Fiscal Year
    2002
  • Support Year
    4
  • Suffix
  • Award Notice Date
    9/24/2003 - 21 years ago
Organizations

Enhancing in vitro Cartilge Synthesis for Human Therapy

DESCRIPTION (Provided by Applicant): The long-term objective of this proposal is to generate a cartilage product with mechanical properties comparable to those of adult articular cartilage for the repair of focal articular defects. Based on previous experimental findings, our hypothesis is that mechanical loading will improve the growth of tissue engineered cartilage in vitro, resulting in a cartilage product with biochemical and biomechanical properties similar to those of articular cartilage. Such tissues are expected to withstand the mechanical forces experienced in vivo better than currently available products, increasing the probability of a successful surgical outcome. To this end, the proposed specific aims of this proposal are as follows: Aim 1: Further develop a novel in house uniaxial compression-perfusion bioreactor system designed and used in the SBIR Phase I into a modular, closed, long-term culture system that supports mechanical modulation and testing of tissues. Aim 2: Determine a culture regime (which will include mechanical loading at specified amplitudes, frequencies, and cycles, as well as perfusion) which results in cartilage constructs with biomechanical and biochemical properties comparable to those of adult articular cartilage. Aim 3: Determine the ability of allogeneic tissue engineered cartilage constructs to successfully repair focal defects on the condylar surface of the patellofemoral joint. PROPOSED COMMERCIAL APPLICATION: Tissue engineering of cartilage in vitro, followed by transplantation for human therapy of articular surface defects.

IC Name
NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES
  • Activity
    R44
  • Administering IC
    AR
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    457986
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    846
  • Ed Inst. Type
  • Funding ICs
    NIAMS:457986\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SYNTHASOME, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92109
  • Organization District
    UNITED STATES